Cutler Group’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$42K Buy
+603
New +$42K 0.01% 422
2023
Q4
Sell
-2,500
Closed -$73K 1438
2023
Q3
$73K Buy
+2,500
New +$73K 0.01% 629
2023
Q2
Hold
0
1488
2023
Q1
Sell
-10
Closed 1578
2022
Q4
$0 Buy
+10
New ﹤0.01% 1861
2022
Q3
Hold
0
2006
2022
Q2
Sell
-1,664
Closed -$61K 1992
2022
Q1
$61K Sell
1,664
-270
-14% -$9.9K ﹤0.01% 973
2021
Q4
$88K Buy
1,934
+1,923
+17,482% +$87.5K ﹤0.01% 975
2021
Q3
$0 Sell
11
-489
-98% ﹤0.01% 2207
2021
Q2
$9K Sell
500
-100
-17% -$1.8K ﹤0.01% 1731
2021
Q1
$13K Sell
600
-6,900
-92% -$150K ﹤0.01% 1567
2020
Q4
$155K Sell
7,500
-500
-6% -$10.3K 0.01% 640
2020
Q3
$173K Buy
+8,000
New +$173K 0.01% 519
2020
Q2
Hold
0
1648
2019
Q1
Sell
-8,500
Closed -$53K 1624
2018
Q4
$53K Buy
+8,500
New +$53K 0.01% 817
2018
Q3
Sell
-100
Closed 1723
2018
Q2
$0 Sell
100
-1,200
-92% ﹤0.01% 1771
2018
Q1
$9K Sell
1,300
-2,800
-68% -$19.4K ﹤0.01% 1415
2017
Q4
$33K Sell
4,100
-6,081
-60% -$48.9K ﹤0.01% 1240
2017
Q3
$147K Buy
10,181
+6,163
+153% +$89K 0.01% 852
2017
Q2
$48K Sell
4,018
-11,434
-74% -$137K ﹤0.01% 1492
2017
Q1
$198K Sell
15,452
-27,900
-64% -$358K 0.01% 840
2016
Q4
$526K Buy
43,352
+20,913
+93% +$254K 0.02% 454
2016
Q3
$205K Buy
22,439
+14,909
+198% +$136K 0.01% 754
2016
Q2
$71K Sell
7,530
-106
-1% -$999 ﹤0.01% 1189
2016
Q1
$53K Buy
7,636
+1,897
+33% +$13.2K ﹤0.01% 1266
2015
Q4
$60K Buy
+5,739
New +$60K ﹤0.01% 1312